JP2022078067A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2022078067A5 JP2022078067A5 JP2022019743A JP2022019743A JP2022078067A5 JP 2022078067 A5 JP2022078067 A5 JP 2022078067A5 JP 2022019743 A JP2022019743 A JP 2022019743A JP 2022019743 A JP2022019743 A JP 2022019743A JP 2022078067 A5 JP2022078067 A5 JP 2022078067A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- composition
- acid molecule
- ebola virus
- encoding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000007523 nucleic acids Chemical class 0.000 claims 9
- 108020004707 nucleic acids Proteins 0.000 claims 7
- 102000039446 nucleic acids Human genes 0.000 claims 7
- 241001115402 Ebolavirus Species 0.000 claims 3
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 2
- 201000011001 Ebola Hemorrhagic Fever Diseases 0.000 claims 1
- 101900067325 Zaire ebolavirus Envelope glycoprotein Proteins 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 238000004520 electroporation Methods 0.000 claims 1
- 230000028993 immune response Effects 0.000 claims 1
- 230000002163 immunogen Effects 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
- 239000013612 plasmid Substances 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024189281A JP2025017370A (ja) | 2016-05-05 | 2024-10-28 | フィロウイルスコンセンサス抗原、核酸構築物及びそれを用いたワクチン、ならびにその使用方法 |
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662332372P | 2016-05-05 | 2016-05-05 | |
| US62/332,372 | 2016-05-05 | ||
| US201662402519P | 2016-09-30 | 2016-09-30 | |
| US62/402,519 | 2016-09-30 | ||
| US201762483979P | 2017-04-11 | 2017-04-11 | |
| US62/483,979 | 2017-04-11 | ||
| PCT/US2017/031215 WO2017192947A1 (en) | 2016-05-05 | 2017-05-05 | Filovirus consensus antigens, nucleic acid constructs and vacciens made therefrom, and methods of using same |
| JP2019510571A JP7029756B2 (ja) | 2016-05-05 | 2017-05-05 | フィロウイルスコンセンサス抗原、核酸構築物及びそれを用いたワクチン、ならびにその使用方法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019510571A Division JP7029756B2 (ja) | 2016-05-05 | 2017-05-05 | フィロウイルスコンセンサス抗原、核酸構築物及びそれを用いたワクチン、ならびにその使用方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024189281A Division JP2025017370A (ja) | 2016-05-05 | 2024-10-28 | フィロウイルスコンセンサス抗原、核酸構築物及びそれを用いたワクチン、ならびにその使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022078067A JP2022078067A (ja) | 2022-05-24 |
| JP2022078067A5 true JP2022078067A5 (enExample) | 2022-09-09 |
| JP7584770B2 JP7584770B2 (ja) | 2024-11-18 |
Family
ID=60203604
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019510571A Active JP7029756B2 (ja) | 2016-05-05 | 2017-05-05 | フィロウイルスコンセンサス抗原、核酸構築物及びそれを用いたワクチン、ならびにその使用方法 |
| JP2022019743A Active JP7584770B2 (ja) | 2016-05-05 | 2022-02-10 | フィロウイルスコンセンサス抗原、核酸構築物及びそれを用いたワクチン、ならびにその使用方法 |
| JP2024189281A Pending JP2025017370A (ja) | 2016-05-05 | 2024-10-28 | フィロウイルスコンセンサス抗原、核酸構築物及びそれを用いたワクチン、ならびにその使用方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019510571A Active JP7029756B2 (ja) | 2016-05-05 | 2017-05-05 | フィロウイルスコンセンサス抗原、核酸構築物及びそれを用いたワクチン、ならびにその使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024189281A Pending JP2025017370A (ja) | 2016-05-05 | 2024-10-28 | フィロウイルスコンセンサス抗原、核酸構築物及びそれを用いたワクチン、ならびにその使用方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US11091518B2 (enExample) |
| EP (1) | EP3452068A4 (enExample) |
| JP (3) | JP7029756B2 (enExample) |
| KR (2) | KR102678400B1 (enExample) |
| CN (2) | CN117887735A (enExample) |
| AU (2) | AU2017261306B2 (enExample) |
| BR (1) | BR112018072719A2 (enExample) |
| CA (1) | CA3023098A1 (enExample) |
| MX (2) | MX2018013524A (enExample) |
| SG (2) | SG10202011017RA (enExample) |
| WO (1) | WO2017192947A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117887735A (zh) * | 2016-05-05 | 2024-04-16 | 宾夕法尼亚大学理事会 | 丝状病毒共有抗原、核酸构建体和由其制成的疫苗及其使用方法 |
| KR20190114963A (ko) * | 2016-12-02 | 2019-10-10 | 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 | 에볼라 바이러스에 대한 사용을 위한 dna 항체 작제물 |
| CN110655572B (zh) * | 2019-10-11 | 2022-08-16 | 中国科学院广州生物医药与健康研究院 | 一种抗丝状病毒gp蛋白的单克隆抗体及其应用 |
| WO2024233996A2 (en) * | 2023-05-11 | 2024-11-14 | The Wistar Institute Of Anatomy And Biology | Vaccines against african swine fever virus, and methods of using same |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8298820B2 (en) | 2010-01-26 | 2012-10-30 | The Trustees Of The University Of Pennsylvania | Influenza nucleic acid molecules and vaccines made therefrom |
| KR102877352B1 (ko) * | 2012-04-12 | 2025-10-29 | 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 | 필로바이러스 공통 항원, 이로부터 제조된 핵산 구조체 및 백신, 및 이를 사용하는 방법 |
| CN114045295A (zh) * | 2013-03-15 | 2022-02-15 | 宾夕法尼亚大学理事会 | 口蹄疫病毒(fmdv)共有蛋白、其编码序列以及由其制造的疫苗 |
| CN107454848B (zh) * | 2014-09-03 | 2021-06-22 | 巴法里安诺迪克有限公司 | 用于诱导针对丝状病毒感染的保护性免疫的方法和组合物 |
| US10166288B2 (en) | 2014-10-01 | 2019-01-01 | The Trustees Of The University Of Pennsylvania | Vaccines having an antigen and interleukin-21 as an adjuvant |
| CN117887735A (zh) * | 2016-05-05 | 2024-04-16 | 宾夕法尼亚大学理事会 | 丝状病毒共有抗原、核酸构建体和由其制成的疫苗及其使用方法 |
-
2017
- 2017-05-05 CN CN202410055051.8A patent/CN117887735A/zh active Pending
- 2017-05-05 MX MX2018013524A patent/MX2018013524A/es unknown
- 2017-05-05 SG SG10202011017RA patent/SG10202011017RA/en unknown
- 2017-05-05 BR BR112018072719-9A patent/BR112018072719A2/pt unknown
- 2017-05-05 SG SG11201809780WA patent/SG11201809780WA/en unknown
- 2017-05-05 JP JP2019510571A patent/JP7029756B2/ja active Active
- 2017-05-05 CN CN201780042299.9A patent/CN110072536B/zh active Active
- 2017-05-05 KR KR1020187035164A patent/KR102678400B1/ko active Active
- 2017-05-05 KR KR1020247020713A patent/KR20240099514A/ko active Pending
- 2017-05-05 AU AU2017261306A patent/AU2017261306B2/en active Active
- 2017-05-05 CA CA3023098A patent/CA3023098A1/en active Pending
- 2017-05-05 EP EP17793414.8A patent/EP3452068A4/en active Pending
- 2017-05-05 US US16/098,912 patent/US11091518B2/en active Active
- 2017-05-05 WO PCT/US2017/031215 patent/WO2017192947A1/en not_active Ceased
-
2018
- 2018-11-05 MX MX2023003934A patent/MX2023003934A/es unknown
-
2021
- 2021-08-17 US US17/404,143 patent/US12240872B2/en active Active
-
2022
- 2022-02-10 JP JP2022019743A patent/JP7584770B2/ja active Active
-
2024
- 2024-05-27 AU AU2024203524A patent/AU2024203524A1/en active Pending
- 2024-10-28 JP JP2024189281A patent/JP2025017370A/ja active Pending
-
2025
- 2025-03-03 US US19/068,349 patent/US20250257101A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022078067A5 (enExample) | ||
| Simon et al. | The virulent satellite RNA of turnip crinkle virus has a major domain homologous to the 3′ end of the helper virus genome | |
| Sanchez et al. | Sequence analysis of the Ebola virus genome: organization, genetic elements, and comparison with the genome of Marburg virus | |
| Ramsburg et al. | A vesicular stomatitis virus recombinant expressing granulocyte-macrophage colony-stimulating factor induces enhanced T-cell responses and is highly attenuated for replication in animals | |
| JP2022166288A5 (enExample) | ||
| JP2019506175A5 (enExample) | ||
| JP2022101658A5 (enExample) | ||
| JP2019519252A5 (enExample) | ||
| JP2006141398A5 (enExample) | ||
| JP2018523668A5 (enExample) | ||
| JP2006524511A5 (enExample) | ||
| JPH09322781A5 (enExample) | ||
| JP2019525914A5 (enExample) | ||
| JP2005511076A5 (enExample) | ||
| CN108753798B (zh) | 一种嗜水气单胞菌疫苗候选外膜蛋白的制备方法及应用 | |
| JP2003503355A5 (enExample) | ||
| CN118903403A (zh) | 虹鳟特异性CpG佐剂及其应用、虹鳟传染性造血器官坏死病核酸疫苗 | |
| RU2005114015A (ru) | Новая полноразмерная геномная рнк вируса японского энцефалита, полуяенная из нее инфекционная кднк jev и их применение | |
| JP2005512518A5 (enExample) | ||
| RU2011137404A (ru) | Варианты гемагглютинина и нейраминидазы гриппа | |
| US7312202B2 (en) | Rationally designed and chemically synthesized promoter for genetic vaccine and gene therapy | |
| CN115948352B (zh) | 一种水泡性口炎病毒的致弱方法及致弱病毒株和应用 | |
| CN103298936A (zh) | 具有新型流感病毒来源的血凝素蛋白基因的重组痘苗病毒 | |
| CN106336455A (zh) | 东北虎α干扰素及其编码基因和应用 | |
| CN116640787A (zh) | 虹彩病毒dna疫苗 |